Luckwel Pharmaceuticals
Financial ratios & Valuation
Historical Multiples (2014 – 2021)
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | Median | |
|---|---|---|---|---|---|---|---|---|---|---|
Valuation Ratios
| ||||||||||
Price/Earnings ratio | -163.62 | -139.12 | -121.14 | -120.43 | -119.28 | -742.55 | -935.46 | -1.15K | -1.15K | -119.28 |
Price/Sales ratio | N/A | 38.68K | 1.15M | -36.22K | 217.16K | 92.45M | N/A | N/A | N/A | -36.22K |
Price/Book Value ratio | -516.35 | -109.59 | 607.15 | -179.73 | -495.48 | -583.79 | -377.80 | -1.12K | -1.12K | -495.48 |
Price/Cash Flow ratio | -178.08K | -150.21K | -126.18K | -133.40K | -124.24K | -742.89K | -1.57M | -2.53M | -2.53K | -133.40K |
Price/Free Cash Flow ratio | -178.08K | -150.21K | -126.18K | -133.40K | -124.24K | -742.89K | -1.57M | -2.53M | -2.53K | -133.40K |
Price/Earnings Growth ratio | N/A | -7.83 | -8.25 | -174.02 | -173.55 | 8.84 | 43.96 | 60.83 | -48.00 | -174.02 |
Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Profitability Indicator Ratios
| ||||||||||
Gross Profit Margin | N/A | 100% | 100% | 100% | 100% | 100% | N/A | N/A | N/A | 100% |
Operating Profit Margin | N/A | -27905.78% | -956300% | 26548.29% | -180766.10% | -12450620% | N/A | N/A | N/A | N/A |
Pretax Profit Margin | N/A | -27805.78% | -956200% | 30077.03% | -182063.72% | -12450520% | N/A | N/A | N/A | N/A |
Net Profit Margin | N/A | -27805.78% | -956200% | 30077.03% | -182063.72% | -12450520% | N/A | N/A | N/A | N/A |
Effective Tax Rate | N/A | -0.35% | -0.01% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets | -171.46% | -459.77% | -360.31% | -974.89% | -2902.70% | -2282.82% | -3116.43% | -934.02% | -934.02% | -974.89% |
Return On Equity | 315.57% | 78.77% | -501.19% | 149.23% | 415.39% | 78.61% | 40.38% | 98.14% | 35.83% | 415.39% |
Return on Capital Employed | 315.57% | 79.05% | -501.24% | 131.72% | 412.43% | 78.62% | 40.38% | 97.90% | 97.90% | 412.43% |
Liquidity Ratios
| ||||||||||
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.09 | N/A |
Quick Ratio | 0.64 | 0.14 | 3.55 | 0.11 | 0.12 | 0.03 | 0.01 | 0.09 | 0.00 | 0.12 |
Cash ratio | 0.46 | 0.12 | 3.55 | 0.07 | 0.12 | 0.03 | 0.00 | 0.00 | 0.00 | 0.12 |
Days of Sales Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Days of Inventory outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Cycle | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Days of Payables Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Conversion Cycle | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Debt Ratios
| ||||||||||
Debt Ratio | 1.46 | 6.79 | 0.27 | 6.24 | 4.41 | 27.54 | 65.25 | 1.06 | 10.51 | 6.24 |
Debt Equity Ratio | -2.69 | -1.16 | 0.38 | -0.95 | -0.63 | -0.94 | -0.84 | -0.11 | -1.10 | -0.63 |
Long-term Debt to Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Total Debt to Capitalization | 1.58 | 7.08 | 0.27 | -21.58 | -1.71 | -18.51 | -5.48 | -0.12 | N/A | -21.58 |
Interest Coverage Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Flow to Debt Ratio | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | N/A | -0.00 |
Company Equity Multiplier | -1.84 | -0.17 | 1.39 | -0.15 | -0.14 | -0.03 | -0.01 | -0.10 | -0.10 | -0.15 |
Cash Flow Ratios
| ||||||||||
Operating Cash Flow / Sales Ratio | N/A | -0.25 | -9.17 | 0.27 | -1.74 | -124.44 | N/A | N/A | N/A | N/A |
Free Cash Flow / Operating Cash Flow Ratio | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Cash Flow Coverage Ratio | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | N/A | -0.00 |
Short Term Coverage Ratio | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -3.97 | -0.00 |
Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |